Here are relevant reports on : regenerative-medicine-market
-
Sustainable Agriculture Market by Type (Organic Farming, Agroecology, Regenerative Agriculture, Conservation Agriculture, and Precision Agriculture), Application (Food Production, Bioenergy, Environmental Services, and Water Management), and Region - Global Forecast to 2029
The global market for sustainable agriculture, estimated to be US$ XX.X billion by 2024, has an impressive growth forecast, with growth expected to reach $XXX.X billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. that is, within the forecast period. The key players in this market include Organic Valley (US), Nature's Path Foods (US), Eden Foods, Inc. (US), Deere & Company (US), Trimble Inc. (US), AGCO Corporation (US), AgJunction LLC (US), Raven Industries, Inc. (US), AG Leader Technology (US), Teejet Technologies (US), Topcon (US), Taranis (Israel), and others
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Regenerative Agriculture Market by Practice (Aquaculture, Agroecology, Agroforestry, Biochar & Terra Preta, Holistically Managed Grazing, No-Till & Pasture Cropping, Silvopasture), Application and Region - Global Forecast to 2027
The regenerative agriculture market is experiencing an exceptional period of growth, with a projected increase from US$ 8.7 billion in 2022 to an incredible US$ 16.8 billion by 2027. Key players in this market include Nestle SA (Switzerland), Danone SA (France), General Mills, Inc (US), Cargill Incorporated (US), Unilever PLC (United Kingdom), Grounded (South Africa), Soil Capital Belgium SPRL (Belgium), Indigo Ag, Inc (US), and Serenity Kids (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Automotive Ultra-Capacitor Market by Power Modules (volts), Application (Start-Stop Application, Regenerative Braking System, Active Suspension), Components, by Transport mode, Electric Vehicle, by Region - Global Forecast to 2025
Ultra-capacitors are electrical energy storage devices. Ultra-capacitors are used in buses, trucks, trains, and other vehicles. The electric vehicle is one of the major areas where the application of ultra-capacitors is expected to grow at a rapid pace. Government subsidies and incentives have provided the manufacturers the required impetus to promote electric vehicles. Ultra-Capacitors in electric vehicles have a high potential in the automotive industry; however, their development requires continuous collaboration between vehicle manufacturers and battery manufacturers.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cryocooler Market by Recuperative Heat Exchanger, Regenerative Heat Exchanger, Heat Dissipation Pipe, Preventive Maintenance Services, Gifford-McMahon Cryocoolers, Stirling Cryocoolers, Joule Thomson Cryocoolers, Military, Space - Global Forecast to 2030
The cryocooler market is expected to grow from USD 3.48 billion in 2025 to USD 4.90 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% during the forecast period. The Key Players Sumitomo Heavy Industries, Ltd. (Japan), Thales (France), AMETEK.Inc. (US), Edwards Vacuum (UK), Chart Industries, Inc. (US), Air Liquide Advanced Technologies (France), ULVAC CRYOGENICS INC. (Japan), RICOR (Israel), Bluefors (Finland), and Northrop Grumman (US).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
The global advanced visualization market, valued at US$3.36 billion in 2023, stood at US$3.78 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$6.55 billion by the end of the period. Technological advancements in advanced visualization tools, the rising need for early detection of diseases, and the growing support from government & private organizations are key factors driving the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe Artificial Intelligence (AI) in Healthcare Market, valued at USD 4.20 billion in 2024, stood at USD 6.12 billion in 2025 and is projected to advance at a resilient CAGR of 39.0% from 2025 to 2030, culminating in a forecasted valuation of USD 31.72 billion by the end of the period. This growth is driven by strong regulatory support for digital transformation and the rising adoption of AI-enabled clinical workflows across European health systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Fluorometer Market by Light source (Lamps, LEDs, Diode Lasers, and Lasers), Application (Chemistry/Biochemistry, Medicine & Others), and End User (Hospitals, Pharmaceutical and Biotechnology Firms & CROs, Others) - Global Forecast to 2023
The global Fluorometer market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing incidence of cancer, advancement in cancer diagnostics, technological advancement in fluorometry are some of the major factors driving the growth of the global fluorometer market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
